> Skip repeated content
photo of Abdulkader Kasabji, MD

Abdulkader Kasabji, MD

Internal Medicine

About Kasabji

Dr. Abdulkader Kasabji completed medical school at the University of Aleppo, Faculty of Medicine. He is experienced in in-patient internal medicine and preoperative medicine with a special interest in oncology.

Prior to joingin HSS, Dr. Kasabji worked as a hospitalist physician at NewYork-Presbyterian Lawrence Hospital and as a teaching attending at Cleveland Clinic Foundation in Cleveland.

Departments

Internal Medicine

Special Expertise

Perioperative Medicine

Patient Stories

Insurance

If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.

Credentials

Appointments

Assistant Attending Physician, Hospital for Special Surgery

Certification

American Board of Internal Medicine

Education

Aleppo University - Faculty of Medicine, 2002

Residency

SUNY Buffalo, 2008

State Licensure

Languages

English, Arabic

Publications by Kasabji

Research

Industry Relationships

Industry Relationships

HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.

As of October 02, 2020, Dr. Kasabji reported no relationships with the healthcare industry.

HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.